|
|
|
Volumn 164, Issue 4, 2002, Pages 479-482
|
|
The myelodysplastic syndrome II. Newer principles of treatment, course, and prognosis;Det myelodysplastiske syndrom II. Nye behandlingsprincipper, forlø og prognose
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIFOSTINE;
CIPROFLOXACIN;
CYCLOSPORIN;
DANAZOL;
DEFEROXAMINE;
DEXAMETHASONE;
ERYTHROPOIETIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
GROWTH FACTOR;
MELPHALAN;
PENTOXIFYLLINE;
THYMOCYTE ANTIBODY;
COLONY STIMULATING FACTOR;
IMMUNOSUPPRESSIVE AGENT;
ACUTE GRANULOCYTIC LEUKEMIA;
ALLOGENIC BONE MARROW TRANSPLANTATION;
BLOOD TRANSFUSION;
BONE MARROW;
CANCER REGRESSION;
CANCER SURVIVAL;
CANCER THERAPY;
CELL LINE;
CHROMOSOME ANALYSIS;
CONTROLLED STUDY;
CYTOPENIA;
DISEASE COURSE;
HIGH RISK PATIENT;
HUMAN;
HUMAN CELL;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION RISK;
LEUKOCYTE COUNT;
MORTALITY;
MYELOBLAST;
MYELODYSPLASTIC SYNDROME;
PROGNOSIS;
SCORING SYSTEM;
SHORT SURVEY;
TREATMENT INDICATION;
TREATMENT OUTCOME;
BONE MARROW TRANSPLANTATION;
REVIEW;
SURVIVAL RATE;
BLOOD TRANSFUSION;
BONE MARROW TRANSPLANTATION;
COLONY-STIMULATING FACTORS;
ERYTHROPOIETIN;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MYELODYSPLASTIC SYNDROMES;
PROGNOSIS;
SURVIVAL RATE;
|
|
EID: 0037148548
PISSN: 00415782
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (2)
|
|
References (10)
|
